ASO Author Reflections: The Value of Serum CEA for Prognostication at Staging and Response Evaluation in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9

Ann Surg Oncol. 2024 Mar;31(3):1842-1843. doi: 10.1245/s10434-023-14815-3. Epub 2024 Jan 5.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adenocarcinoma* / pathology
  • Biomarkers, Tumor
  • CA-19-9 Antigen
  • Carcinoembryonic Antigen
  • Humans
  • Neoplasm Staging
  • Pancreatic Neoplasms* / pathology
  • Prognosis

Substances

  • CA-19-9 Antigen
  • Biomarkers, Tumor
  • Carcinoembryonic Antigen